Immunotherapy Offers New Hope in Triple Negative Breast Cancer

Results from the Impassion 130 clinical trial published in theNew England Journal of Medicine have demonstrated that immunotherapy can improve survival in breast cancer especially in anti-programmed cell death ligand 1 PD-1 patients The results were seen [...]

Herceptin Biosimilar Herzuma Approved for Certain Breast Cancer Indications

The FDA has approved Celltrion and Tevas Herzuma trastuzumab-pkrb a biosimilar trastuzumab referencing Herceptin for the treatment of HER2-positive breast cancer Herzuma is the second oncology biosimilar approval in the United States in the past month Spe [...]

Delaying Adjuvant Chemotherapy Associated With Worse Outcomes for Patients With Triple-negative Breast Cancer

SAN ANTONIO Patients with triple-negative breast cancer who delayed starting adjuvant chemotherapy for more than 30 days after surgery were at significantly higher risk for disease recurrence and death compared with those who started the treatment in the [...]

Trastuzumab emtansine Improves Treatment of Early Stage HER 2-positive Breast Cancer

Adjuvant trastuzumab emtansine showed improved disease-free survival compared with trastuzumab in HER2-positive early breast cancer Patients with HER 2-positive early stage breast cancer with residual disease who received adjuvant trastuzumab emtansine T- [...]

Oxybutynin Decreased Frequency of Hot Flashes, Improved Quality of Life for Breast Cancer Survivors

Treatment with oxybutynin helped reduce the frequency and intensity of hot flashes for women who could not take hormone replacement including breast cancer survivors according to results of a trial presented at the 2018 San Antonio Breast Cancer Symposium [...]

Choice of surgery may affect quality of life for young breast cancer survivors

Even as more young women with breast cancer opt to have mastectomies many experience a persistent decline in their sexual and psychosocial well-being following the procedure as detailed in new research by Dana-FarberBrigham and Womens Cancer Center The fi [...]

Acupuncture Reduces Aromatase Inhibitor Joint Pain in Women with Breast Cancer

According to a well designed study presented at the 2017 San Antonio Breast Cancer Symposium acupuncture is effective in reducing pain and stiffness associated with aromatase inhibitor AI therapy in women with early-stage breast cancer1 Stiffness and join [...]

Kisqali® Improves Outcomes of Premenopausal Women with HR+/HER2- Advanced Breast Cancer

It was announced today that results from the Phase III MONALEESA-7 trial evaluating Kisqali ribociclib in combination endocrine-based therapy in premenopausal or perimenopausal women with hormone-receptor positive human epidermal growth factor receptor-2 [...]